[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
[ Wed, Aug 14th 2024 ]: WOPRAI
Joon Lee Maintained (ADVM) at Strong Buy with Decreased Target to $40 on, Aug 14th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Joon Lee of Truist Securities, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy with Decreased Target from $60 to $40 on, Aug 14th, 2024.
Joon has made no other calls on ADVM in the last 4 months.
There are 5 other peers that have a rating on ADVM. Out of the 5 peers that are also analyzing ADVM, 1 agrees with Joon's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $12 on, Tuesday, August 13th, 2024
These are the ratings of the 4 analyists that currently disagree with Joon
- Matthew Caufield of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Tuesday, August 13th, 2024
- Daniil Gataulin of "Chardan Capital" Maintained at Strong Buy with Increased Target to $40 on, Thursday, July 18th, 2024
- Francois Brisebois of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Tuesday, June 25th, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $22 on, Monday, April 29th, 2024